CNRS Scientists have deciphered the activation pathway of bemnifosbuvir, a drug candidate initially in development to treat hepatitis C virus (HCV). The findings of the research team, led by CNRS scientists, unlock new opportunities to boost the efficacy of this type of drug against other RNA viruses, such as the ones that cause Covid-19 and dengue fever.
TDR’s Top 5 Psychedelic Developments For The Week Of June 12
Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of June 12. Aside from presenting a synopsis of events, we provide
June 17, 2023